Reye's syndrome in the United States from 1981 through 1997

New England Journal of Medicine

Volumn 340, Issue 18, 1999, Pages 1377-1382

  Belay, Ermias D ^a,b   Bresee, Joseph S ^a   Holman, Robert C ^a   Khan, Ali S ^a   Shahriari, Abtin ^a   Schonberger, Lawrence B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; FATALITY; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; REYE SYNDROME; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; AGE FACTORS; AMMONIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; POPULATION SURVEILLANCE; REYE SYNDROME; RISK FACTORS; SALICYLATES; SEASONS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VIRUS DISEASES;

EID: 0033529015     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199905063401801     Document Type: Article

References (30)

1. Brain WR, Hunter D, Turnbull HM. Acute meningo-encephalomyelitis of childhood: report of 6 cases. Lancet 1929;1:221-7.
2. Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 1963;2:749-52.
3. Johnson GM, Scurletis TD, Carroll NB. A study of sixteen fatal cases of encephalitis-like disease in North Carolina children. N C Med J 1963; 24:464-73.
4. Roe CR, Millington DS, Maltby DA, Kinnebrew P. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. J Pediatr 1986;108:13-8.
5. Rowe PC, Valle D, Brusilow SW. Inborn errors of metabolism in children referred with Reye's syndrome: a changing pattern. JAMA 1988;260: 3167-70.
6. Forsyth BW, Shapiro ED, Horwitz RI, Viscoli CM, Acampora D. Misdiagnosis of Reye's-like illness. Am J Dis Child 1991;145:964-6.
7. Green A, Hall SM. Investigation of metabolic disorders resembling Reye's syndrome. Arch Dis Child 1992;67:1313-7.
8. Partin JS, Daugherty CC, McAdams AJ, Partin JC, Schubert WK. A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome. Hepatology 1984;4:687-90.
9. Corey L, Rubin RJ, Hattwick MAW, Noble GR, Cassidy E. A nationwide outbreak of Reye's syndrome: its epidemiologic relationship to influenza B. Am J Med 1976;61:615-25.
10. Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF. Reye's syndrome and salicylate use. Pediatrics 1980;66:859-64.
11. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reye's syndrome. JAMA 1982;247:3089-94.
12. Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye's syndrome and medication use. JAMA 1982;248:687-91.
13. Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study on Reye's syndrome and medications: report of the pilot phase. N Engl J Med 1985;313:849-57.
14. Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study of Reye's syndrome and medications: report of the main study. JAMA 1987;257:1905-11. [Erratum, JAMA 1987;257:3366.]
15. Follow-up on Reye's syndrome - United States. MMWR Morb Mortal Wkly Rep 1980;29:321-2.
16. Reye syndrome - Ohio, Michigan. MMWR Morb Mortal Wkly Rep 1980;29:532, 537-9.
17. National surveillance for Reye syndrome, 1981: update, Reye syndrome and salicylate usage. MMWR Morb Mortal Wkly Rep 1982;31:53-6, 61.
18. Surgeon General's advisory on the use of salicylates and Reye syndrome. MMWR. Morb Mortal Wkly Rep 1982;31:289-90.
19. Davis DL, Buffler P. Reduction of deaths after drug labelling for risk of Reye's syndrome. Lancet 1992;340:1042.
20. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied regression analysis and other multivariable methods. Pacific Grove, Calif.: Duxbury Press, 1998.
21. Arrowsmith JB, Kennedy DL, Kuritsky JN, Faich GA. National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985. Pediatrics 1987;79:858-63.
22. Remington PL, Rowley D, McGee H, Hall WN, Monto AS. Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 1986;77:93-8.
23. Taylor JP, Gustafson TL, Johnson CC, Brandenburg N, Glezen WP. Antipyretic use among children during the 1983 influenza season. Am J Dis Child 1985;139:486-8.
24. Reye syndrome - Ohio, Michigan. MMWR Morb Mortal Wkly Rep 1997;46:750-5.
25. Nelson DB, Sullivan-Bolyai JZ, Marks JS, Morens DM, Schonberger L. Reye syndrome: an epidemiologic assessment based on national surveillance 1977-1978 and a population based study in Ohio, 1973-1977. In: Crocker JFS, ed. Reye syndrome II. New York: Grune & Stratton, 1979:33-49.
26. Hardie RM, Newton LH, Bruce JC, et al. The changing clinical pattern of Reye's syndrome 1982-1990. Arch Dis Child 1996;74:400-5.
27. Remington PL, Shabino CL, McGee H, Preston G, Sarniak AP, Hall WN. Reye syndrome and juvenile rheumatoid arthritis in Michigan. Am J Dis Child 1985;139:870-2.
28. Rennebohm RM, Heubi JE, Daugherty CC, Daniels SR. Reye syndrome in children receiving salicylate therapy for connective tissue disease. J Pediatr 1985;107:877-80.
29. Pinsky PF, Hurwitz ES, Schonberger LB, Gunn WJ. Reye's syndrome and aspirin: evidence for a dose-response effect. JAMA 1988;260:657-61.
30. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998;47(RR-6):1-26.